Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07176572
Starting soon Phase 4

Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation and Dexketoprofen in Renal Colic

NCT07176572 · tracked via the Priya Life Science Turkey tracker
Sponsor
Adiyaman University Research Hospital
Phase
Phase 4
Started
2026-03-01
Last updated
2025-10-02

Condition(s) studied

Renal Colic

Investigational drug(s) / intervention(s)

TENSDexketoprofen Trometamol

TENS: Transcutaneous electrical nerve stimulation (TENS) treatment will be activated + NS IV Infusion 100 ml

Dexketoprofen Trometamol: 50 mg dexketoprofen trometamol in 100 ml normal saline solution + Transcutaneous electrical nerve stimulation treatment will not be activated.

Study summary

The aim of this study was to compare the analgesic efficacy of transcutaneous electrical nerve stimulation (TENS) and dexketoprofen trometamol in patients presenting to the emergency department due to renal colic.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: \- Aged 18 years or over with a definite diagnosis of renal colic Exclusion Criteria: * Patients who refuse to participate in the study * Pregnant women * Breastfeeding women * Haemodynamically unstable * Evidence of peritoneal inflammation * Patients who were taking analgesics at the time of initial presentation * Unconsciousness or inability to communicate * Contraindications to applying TENS or using the drug in the study.

Primary outcome measure(s)

  • Change of the intensity of pain — 15 minutes and 30 minutes after the administration of the study interventions
    Pain intense will be measured by 100 mm visual analog scale (Zero; no pain and 100 mm; the worst pain) after 15th and 30th minutes later the administration of the study interventions

Trial sites (1)

FacilityCityRegionStatus
Adiyaman University Medical Faculty Adıyaman Turkey (Türkiye)

More Adiyaman University Research Hospital trials in Turkey

Effect of Hormonal Cahanges During Menstrual Cycle on Subcostal Transversus Abdominis Plane Block Starting soon
Thoracic vs Lumbar Spinal Anesthesia for Cesarean Delivery Starting soon
AI-Generated Maternal Voice Storytelling During Pediatric Adenotonsillectomy Starting soon

Other trials for the same condition

Use of POCUS and STONE Criteria Together in the Diagnosis of Nephrolithiasis Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07176572 on ClinicalTrials.gov ↗ ← All trials in Turkey